These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29968198)

  • 1. Triple Therapy: When, if Ever?
    Mihatov N; Secemsky EA; Elmariah S
    Curr Treat Options Cardiovasc Med; 2018 Jul; 20(7):61. PubMed ID: 29968198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation: The RE-DUAL PCI Trial Subanalysis.
    Ten Berg JM; de Veer A; Oldgren J; Steg PG; Zateyshchikov DA; Jansky P; Seung KB; Hohnloser SH; Lip GYH; Nordaby M; Kleine E; Bhatt DL; Cannon CP;
    JACC Cardiovasc Interv; 2019 Dec; 12(23):2331-2341. PubMed ID: 31806214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple Antithrombotic Therapy for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
    Kerneis M; Talib U; Nafee T; Daaboul Y; Pahlavani S; Pitliya A; Furqan MM; Datta S; Kazmi HA; Younes A; Gibson CM
    Prog Cardiovasc Dis; 2018; 60(4-5):524-530. PubMed ID: 29397950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation: Insights From the PIONEER AF-PCI Trial.
    Kerneis M; Yee MK; Mehran R; Nafee T; Bode C; Halperin JL; Peterson ED; Verheugt FWA; Wildgoose P; van Eickels M; Lip GYH; Cohen M; Fox KAA; Gibson CM
    Circ Cardiovasc Interv; 2019 Nov; 12(11):e008160. PubMed ID: 31707805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is dual therapy the correct strategy in frail elderly patients with atrial fibrillation and acute coronary syndrome?
    Menditto A; Antonicelli R
    J Geriatr Cardiol; 2020 Jan; 17(1):51-57. PubMed ID: 32133036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous Coronary Intervention in Patients Who Have an Indication for Oral Anticoagulation - an Evidence-based Approach to Antithrombotic Therapy.
    Gallagher S; Archbold RA
    Interv Cardiol; 2015 Mar; 10(1):16-21. PubMed ID: 29588668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-Analysis Comparing the Safety and Efficacy of Dual Versus Triple Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
    Cavallari I; Patti G
    Am J Cardiol; 2018 Mar; 121(6):718-724. PubMed ID: 29373105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The optimal management of patients on oral anticoagulation undergoing coronary artery stenting. The 10th Anniversary Overview.
    Rubboli A; Faxon DP; Juhani Airaksinen KE; Schlitt A; Marín F; Bhatt DL; Lip GY
    Thromb Haemost; 2014 Dec; 112(6):1080-7. PubMed ID: 25298351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in Aortic Stenosis: Review of Antiplatelet/Anticoagulant Therapy Management with Transcatheter Aortic Valve Replacement (TAVR): TAVR with Recent PCI, TAVR in the Patient with Atrial Fibrillation, and TAVR Thrombosis Management.
    Sherwood MW; Vora AN
    Curr Cardiol Rep; 2018 Oct; 20(12):130. PubMed ID: 30311013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant Use of Antiplatelets and Anticoagulants in Patients with Coronary Heart Disease and Atrial Fibrillation: What Do Recent Clinical Trials Teach Us?
    Lam DH; Bell SM; Hira RS
    Curr Atheroscler Rep; 2018 Jan; 20(1):4. PubMed ID: 29349596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial.
    Kerneis M; Gibson CM; Chi G; Mehran R; AlKhalfan F; Talib U; Pahlavani S; Mir M; Bode C; Halperin JL; Nafee T; Peterson ED; Verheugt FWA; Wildgoose P; van Eickels M; Lip GYH; Fox KAA; Cohen M
    JACC Cardiovasc Interv; 2018 Apr; 11(7):626-634. PubMed ID: 29550085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antithrombotic treatment in acute coronary syndrome and atrial fibrillation].
    Darius H; Görge G; Spiecker M; Schinzel H
    Herz; 2019 Feb; 44(1):29-34. PubMed ID: 30689009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Triple Therapy and Dual Therapy With Direct Oral Anticoagulants Compared to Warfarin.
    Amano H; Saito D; Yabe T; Okubo R; Toda M; Ikeda T
    Int Heart J; 2017 Aug; 58(4):570-576. PubMed ID: 28701676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemic and bleeding events in patients with myocardial infarction undergoing percutaneous coronary intervention who require oral anticoagulation: Insights from the Canadian observational AntiPlatelet sTudy.
    Sra S; Tan MK; Mehta SR; Fisher HN; Déry JP; Welsh RC; Eisenberg MJ; Overgaard CB; Rose BF; Siega AJ; Cheema AN; Wong BY; Henderson MA; Lutchmedial S; Lavi S; Goodman SG; Yan AT;
    Am Heart J; 2016 Oct; 180():82-9. PubMed ID: 27659886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Relevance of Anticoagulation and Dual Antiplatelet Therapy to the Outcomes of Patients With Atrial Fibrillation and Recent Percutaneous Coronary Intervention With Stent.
    De Vecchis R; Cantatrione C; Mazzei D
    J Clin Med Res; 2016 Feb; 8(2):153-61. PubMed ID: 26767085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Vitamin K Oral Anticoagulants (NOAC) Versus Vitamin K Antagonists (VKA) for Atrial Fibrillation with Elective or Urgent Percutaneous Coronary Intervention: A Meta-Analysis with a Particular Focus on Combination Type.
    Eyileten C; Postula M; Jakubik D; Toma A; Mirowska-Guzel D; Patti G; Renda G; Siller-Matula JM
    J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32295160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple Antithrombotic Therapy after Percutaneous Coronary Intervention (PCI) in Patients with Indication for Oral Anticoagulation: Data from a Single Center Registry.
    Staudacher DL; Kaiser M; Hehrlein C; Bode C; Ahrens I
    PLoS One; 2015; 10(10):e0140101. PubMed ID: 26439131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial.
    Kopin D; Jones WS; Sherwood MW; Wojdyla DM; Wallentin L; Lewis BS; Verheugt FWA; Vinereanu D; Bahit MC; Halvorsen S; Huber K; Parkhomenko A; Granger CB; Lopes RD; Alexander JH
    Am Heart J; 2018 Mar; 197():133-141. PubMed ID: 29447773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Saito Y; Kobayashi Y
    J Cardiol; 2019 Jan; 73(1):1-6. PubMed ID: 30293674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation in Acute Coronary Syndrome: Review of Major Therapeutic Advances.
    Pop C; Matei C; Petris A
    Am J Ther; 2019; 26(2):e184-e197. PubMed ID: 30839367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.